Evidence map›Paper›PMID 38744864›Full record

ArticleScientific reports2024

Distinct cytokine profiles in late pregnancy in Ugandan people with HIV.

Lisa M Bebell, Joseph Ngonzi, Audrey Butler, Elias Kumbakumba, Julian Adong, Carolin Loos, Adeline A Boatin, Ingrid V Bassett, Mark J Siedner, Paige L Williams and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lisa M BebellMedical Practice Evaluation Center and Center for Global Health, Massachusetts General Hospital Division of Infectious Diseases, GRJ-504, 55 Fruit St, Boston, MA, 02114, USA. lbebell@mgh.harvard.edu.
Joseph NgonziDepartment of Obstetrics and Gynaecology, Mbarara University of Science and Technology, Mbarara, Uganda.
Audrey ButlerState University of New York Upstate Medical University, Syracuse, NY, USA.
Elias KumbakumbaDepartment of Paediatrics and Child Health, Mbarara University of Science and Technology, Mbarara, Uganda.
Julian AdongDepartment of Paediatrics and Child Health, Mbarara University of Science and Technology, Mbarara, Uganda.
Carolin LoosRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Adeline A BoatinDepartment of Obstetrics and Gynecology and Center for Global Health, Massachusetts General Hospital, Boston, MA, USA.
Ingrid V BassettDivision of Infectious Diseases and Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
Mark J SiednerDivision of Infectious Diseases and Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
Paige L WilliamsDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Heather MattieDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Bethany Hedt-GauthierDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Katharine F B CorreiaDepartment of Mathematics and Statistics, Amherst College, Amherst, MA, USA.
Erin Lake *Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Galit Alter *Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ARTHUR Y KIM · 2004 to 2026
$94.4M
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,75N93019C00052 · NIAID · UNIVERSITY OF GEORGIA · PI ROSS, TED · 2019 to 2025
$74.6M
Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Kristian Graugaard Andersen · 2018 to 2026
$32.0M
Institutional Career Development CoreKL2TR002542 · NCATS · HARVARD MEDICAL SCHOOL · PI BREDELLA, MIRIAM ANTOINETTE, RUTKOVE, SEWARD B. · 2018 to 2022
$8.7M
Demystifying the antiviral activity of the IgG3+ antibody responseR37AI080289 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALTER, GALIT · 2015 to 2022
$5.8M
Immunologic Signatures of SARS-CoV-2 Vaccination and DiseaseU01CA260476 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BAROUCH, DAN H. · 2020 to 2024
$3.7M
SARS-CoV-2 Variant TestingR01AI146785 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LINGWOOD, DANIEL · 2020 to 2024
$3.3M
Mentoring in patient-oriented research on HIV prevention in the US and South AfricaK24AI141036 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Ingrid Valerie Bassett · 2019 to 2026
$1.1M
HIV Infection, Placental Inflammation, and Early Childhood Outcomes in HIV-exposed, Uninfected Infants in UgandaK23AI138856 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BEBELL, LISA M · 2019 to 2023
$1.1M
CHLAMYDIA PNEUMONIAE AND MACROPHAGES IN ATHEROSCLEROSISR01AI042790 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI BYRNE, GERALD IRWIN · 1999 to 2003
$983k
American Society of Tropical Medicine and Hygiene Burroughs Wellcome Postdoctoral Fellowship in Tropical Infectious DiseasesCivic CIVIC75N93019C0005Harvard Catalyst KL2TR002542Harvard University Center for AIDS Research P30AI060354National Institute of Allergy and Infectious Diseases 3R37AI080289-11S1National Institute of Allergy and Infectious Diseases K23AI138856National Institute of Allergy and Infectious Diseases K24AI141036National Institute of Allergy and Infectious Diseases,United States R01AI146785NCATS NIH HHS KL2 TR002542NCI NIH HHS U01 CA260476NIAID NIH HHS K23 AI138856NIAID NIH HHS K24 AI141036NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI042790NIAID NIH HHS R01 AI146785NIAID NIH HHS R37 AI080289NIAID NIH HHS U19 AI135995NIH HHS 75N93019C00052
6 · The paper itself

Abstract

During pregnancy, multiple immune regulatory mechanisms establish an immune-tolerant environment for the allogeneic fetus, including cellular signals called cytokines that modify immune responses. However, the impact of maternal HIV infection on these responses is incompletely characterized. We analyzed paired maternal and umbilical cord plasma collected during labor from 147 people with HIV taking antiretroviral therapy and 142 HIV-uninfected comparators. Though cytokine concentrations were overall similar between groups, using Partial Least Squares Discriminant Analysis we identified distinct cytokine profiles in each group, driven by higher IL-5 and lower IL-8 and MIP-1α levels in pregnant people with HIV and higher RANTES and E-selectin in HIV-unexposed umbilical cord plasma (P-value < 0.01). Furthermore, maternal RANTES, SDF-α, gro

Indexed as

CytokinesHIV InfectionsPregnancy Complications, InfectiousAdultFemaleFetal BloodHumansPregnancyUgandaYoung AdultCytokines

Identifiers

PMID38744864
PMCPMC11093984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.